推荐应用
DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of mental retardation in females.
推荐稀释比 WB: 1/500-1/1000 IHC: 1/100-1/200 IF: 1/50-1/200 FC: 1/50-1/100 ELISA: 1/10000
Western
Western blot analysis of MECP2 in A431 (1) and MCF-7 (2) cell lysate using MECP2 antibody.
Immunohistochemistry
Immunohistochemistry analysis of paraffin-embedded human ovarian cancer tissues using MECP2 antibody.
Immunocytochemistry
Immunocytochemistry analysis of MECP2 in Hela cells using MECP2 antibody (green),and DAPI(blue). Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.
Flow
Flow Cytometry analysis of Hela cells using MECP2 antibody (green) and negative control (red).
-25 ~ -15℃保存,收到货之后有效期1年,避免反复冻融。
【应用方向】单细胞表观测序中的抗体应用
13
2026-07-29
【选购指南】类器官研究之构建与起始细胞鉴定抗体推荐
307
2026-07-21
【选购指南】类器官研究之功能成熟度评估抗体推荐
270
2026-07-21
【应用方向】趋化因子信号传导通路——身体“信号导航”解析
284
2026-07-21
【选购指南】重度抑郁症(MDD)通路研究抗体推荐
242
2026-07-21
【选购指南】帕金森病(PD)代谢机制核心抗体研究指南
276
2026-07-21
【应用方向】抗体助力心脏免疫研究——解锁心衰防治新方向
234
2026-07-21
【应用方向】抗体助力心肌肥大与心衰研究:从基础探索到科研应用
267
2026-07-21
【应用方向】抗体助力癌症代谢通路研究——肿瘤代谢科普与研究工具指南
271
2026-07-21
【应用方向】抗体应用研究——肿瘤表观遗传学通路
11273
2026-04-14
【应用方向】造血干细胞研究相关抗体选型与推荐
18069
2026-04-14
【技术讲解】抗体赋能心肌梗死研究—精准靶向,助力科研突破
7335
2026-04-14
【应用方向】抗体应用研究——神经谱系标记物
10001
2026-04-14
【应用方向】间充质干细胞(MSC)应用研究抗体推荐—用于表型表征、机制研究与分化评估的常用靶标与抗体选型参考
20277
2026-04-14
【应用方向】抗体应用研究—细胞死亡
20264
2026-07-16





